≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback
info icon

This is a non-core endpoint: only basic statistics are computed.

Benign neoplasm: Tongue

Endpoint Browser

CD2_BENIGN_TONGUE_EXALLC

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

None

-

2. Check conditions

None

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — D10.1
  • Hospital discharge: ICD-9 — 2101
  • Hospital discharge: ICD-8 — 2101
  • Cause of death: ICD-10 — D10.1
  • Cause of death: ICD-9 — 2101
  • Cause of death: ICD-8 — 2101

2 out of 7 registries used, show all original rules.

-

4. Check minimum number of events

None

-

5. Include endpoints

None

-

6. Filter based on genotype QC (FinnGen only)

None

-

Control definitions (FinnGen only)

Control exclude
C3_CANCER, C3_CANCER_WIDE

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF2
Parent code in ICD-10
D10
Name in latin
Neoplasma benignum linguae

Case counts by codes

↥

FinnGen case counts by registry codes:

No upset plot: script not run.

No upset table: script not run.

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

All Female Male
Number of individuals 986 561 425
Unadjusted period prevalence (%) 0.19 0.19 0.19
Median age at first event (years) 57.83 56.69 59.32

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
884
Matched controls
8840
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D10.19
ICD-10 Finland
Benign tumor of the tongue UNS
+∞
323.0
413
*
EJA10
NOMESCO Finland
Biopsy of tongue or floor of mouth
124.9
297.6
310
38
D10.12
ICD-10 Finland
Bone tumor of the tip of the tongue
+∞
191.8
177
*
D10.10
ICD-10 Finland
Benign tumor at the base of the tongue
+∞
167.1
155
*
EJB10
NOMESCO Finland
Excision of lesion of apex or body of tongue
475.1
163.2
158
*
130
Kela drug reimbursment
Malignant tumour
+∞
91.3
86
*
D10.11
ICD-10 Finland
Benign tumor in the back of the tongue
+∞
79.4
75
*
C02.11
ICD-10 Finland
Malignant neoplasm of border of tongue
+∞
74.0
70
*
WF002
NOMESCO Finland
Radical radiotherapy
195.2
53.6
55
*
D10.1
ICD-10 Finland
Benign neoplasm: Tongue
282.1
52.7
53
*
PJA12
NOMESCO Finland
Sentinel node biopsy
+∞
52.6
50
*
A04AA02
ATC
granisetron; systemic, transdermal
493.3
47.8
47
*
115
Kela drug reimbursment
Breast cancer
+∞
45.2
43
*
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
459.9
44.6
44
*
H02AB02
ATC
dexamethasone; systemic
21.8
42.9
63
31
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
3.0
42.2
319
1406
A03FA01
ATC
metoclopramide; systemic, rectal
3.9
40.7
190
581
504
Kela drug reimbursment
Conditions requiring daily forced enteral nutrition
36.0
39.8
51
15
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
139.5
38.0
40
*
8070/3-C02.1
ICD-O-3
Squamous cell carcinoma, NOS, of border of tongue
+∞
37.8
36
*
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
36.7
35
*
C01
ICD-10 Finland
Malignant neoplasm of base of tongue
+∞
36.7
35
*
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
36.7
35
*
C61
ICD-10 Finland
Malignant neoplasm of prostate
371.8
36.2
36
*
JDB10
NOMESCO Finland
Percutaneous gastrostomy
27.2
35.8
49
19
EJB40
NOMESCO Finland
Hemiglossectomy
+∞
33.5
32
*
WF003
NOMESCO Finland
Adjuvant radiotherapy
+∞
33.5
32
*
PJD71
NOMESCO Finland
Extended sparing excision of cervical lymph nodes
+∞
32.5
31
*
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
171.2
31.9
33
*
EP1CG
NOMESCO Finland
Extensive MRI examination of soft tissue of neck with high intesity magnet
29.3
31.4
42
15
EP1AE
NOMESCO Finland
Neck ultrasound examination
6.7
31.1
82
133
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
11.0
30.6
59
57
21010
ICD-8 Finland
Benign neoplasm of buccal cavity and pharynx, Tongue
+∞
30.4
29
*
D10.14
ICD-10 Finland
Lingual tonsil
312.6
30.0
30
*
WX408
NOMESCO Finland
General anesthesy, balanced
2.6
30.0
269
1265
A07AA02
ATC
nystatin; oral
4.8
29.2
102
232
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
28.3
27
*
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
27.2
26
*
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
27.2
26
*
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
+∞
27.2
26
*
ZZQ00
NOMESCO Finland
Free microvascular graft of skin
279.2
26.9
27
*
D20
ICPC
Mouth/tongue/lip symptom/complaint
5.3
25.8
81
164
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
2.2
25.5
392
2368
PJD81
NOMESCO Finland
Excision of lymph nodes from upper part of neck
+∞
25.1
24
*
XX3DW
NOMESCO Finland
Time consuming IT work
5.3
24.3
77
157
N02AA05
ATC
oxycodone; systemic
3.3
24.3
134
455
Z2221
NOMESCO Finland
Medical doctor
2.3
24.0
269
1395
WX110
NOMESCO Finland
Local anesthesy
2.1
23.9
608
4502
UJC01
NOMESCO Finland
Scopy of lower throat
18.7
23.7
36
20
SAA03
NOMESCO Finland
Extended examination of mouth
2.1
23.6
361
2155
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.1
23.1
389
2415
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
+∞
23.0
22
*
EJB20
NOMESCO Finland
Excision of lesion of base of tongue
+∞
23.0
22
*
ZX090
NOMESCO Finland
Other technic of radiotherapy
+∞
23.0
22
*
L03AA13
ATC
pegfilgrastim; parenteral
+∞
23.0
22
*
HAB40
NOMESCO Finland
Wedge excision of mammary gland
32.1
21.6
28
9
K13.29
ICD-10 Finland
Indefinite leukoplakia
15.1
21.3
35
24
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
4.8
21.3
73
163
ZX070
NOMESCO Finland
Intensity modified radiotherapy
+∞
20.9
20
*
A04AA55
ATC
palonosetron, combinations; systemic
+∞
20.9
20
*
GDA98
NOMESCO Finland
Other bronchoscopic incision, excision of lesion or repair of lung
38.2
20.9
26
7
ZXD10
NOMESCO Finland
Scheduled procedure
2.0
20.3
352
2178
K14.9
ICD-10 Finland
Disease of tongue, unspecified
33.4
20.3
26
8
D10.13
ICD-10 Finland
Benign tumor under the tongue
+∞
19.9
19
*
A04AD12
ATC
aprepitant; systemic
+∞
19.9
19
*
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
204.4
19.6
20
*
A04AA01
ATC
ondansetron; systemic, rectal
7.0
19.3
48
72
GBB00
NOMESCO Finland
Tracheostomy
17.2
19.3
30
18
HA003
NOMESCO Finland
Radiotherapy after partial ablation of mammary gland
+∞
18.8
18
*
116
Kela drug reimbursment
Prostate cancer
+∞
18.8
18
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
+∞
18.8
18
*
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
18.8
18
*
8070/3-C01.9
ICD-O-3
Squamous cell carcinoma, NOS, of base of tongue, NOS
+∞
18.8
18
*
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
18.8
18
*
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
4.7
18.7
65
147
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
193.9
18.6
19
*
UDQ12
NOMESCO Finland
Flexible laryngoscopy
3.8
18.0
80
228
JN4BD
NOMESCO Finland
Extensive body CT
4.1
18.0
73
192
WX402
NOMESCO Finland
General anaesthesia
2.6
18.0
142
603
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
6.5
18.0
47
76
C02.9
ICD-10 Finland
Malignant neoplasm: Tongue, unspecified
+∞
17.8
17
*
C44.51
ICD-10 Finland
Basocellular carcinoma of the skin on the torso
+∞
17.8
17
*
R13
ICD-10 Finland
Dysphagia
3.5
17.8
87
269
L02BG04
ATC
letrozole; oral
12.8
17.7
31
25
HA1AA
NOMESCO Finland
X-ray mammography
6.0
17.6
49
86
A02BC02
ATC
pantoprazole; systemic
1.9
17.6
567
4314
EN1BD
NOMESCO Finland
Very extensive CT examination of mouth and soft tissues of neck
14.2
17.4
29
21
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.4
17.3
171
818
SBB00
NOMESCO Finland
Fotograf of mouth and teeth
5.1
17.0
54
111
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
+∞
16.7
16
*
C02.10
ICD-10 Finland
Malignant neoplasm of tip of tongue
+∞
16.7
16
*
L01BC06
ATC
capecitabine; oral
+∞
16.7
16
*
HAC20
NOMESCO Finland
Total mastectomy
173.1
16.5
17
*
SAA04
NOMESCO Finland
Special inverstigation of mouth
3.7
16.5
74
213
ENA10
NOMESCO Finland
Biopsy of pharynx
48.5
16.1
19
*
K14.61
ICD-10 Finland
Glossodynia
11.0
16.1
30
28
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.0
16.0
266
1587
SXA10
NOMESCO Finland
Epithel biopsy of mouth
9.4
15.8
32
35
PJ5AN
NOMESCO Finland
Localisation of sentinell lymphnode with isotope imaging
+∞
15.7
15
*
PJD52
NOMESCO Finland
Block dissection of axillary lymph nodes
162.8
15.5
16
*
R22.9
ICD-10 Finland
Localized swelling, mass and lump, unspecified
3.3
15.5
82
269
Z51.5
ICD-10 Finland
Palliative care
7.3
15.2
36
51
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
2.0
15.2
220
1242
WZC30
NOMESCO Finland
Teaching
2.7
15.1
106
419
N02BE01
ATC
paracetamol; systemic, rectal
2.0
15.0
744
6380
R4110
NOMESCO Finland
Physiotherapy
2.0
14.9
230
1327
8070/3-C02.9
ICD-O-3
Squamous cell carcinoma, NOS, of tongue, NOS
+∞
14.6
14
*
2101A
ICD-9 Finland
Benign neoplasm of lip, oral cavity and pharynx, Tongue
+∞
14.6
14
*
JCW98
NOMESCO Finland
Other transluminal endoscopic procedure on oesophagus
+∞
14.6
14
*
D37.08
ICD-10 Finland
Tumor of uncertain or unknown nature in other part of lip, oral cavity and pharynx
81.5
14.6
16
*
PJ3AT
NOMESCO Finland
Cytology of lymphnode with ultrasound guidance
36.7
14.5
18
5
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
4.1
14.1
56
145
UDH02
NOMESCO Finland
Rhinopharyngoscopy
3.1
14.1
79
268
J01DB01
ATC
cefalexin; oral
1.9
14.0
705
5964
A01AB09
ATC
miconazole; local oral
2.6
13.8
105
434
S18
ICPC
Laceration/cut
1.8
13.8
352
2407
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
76.3
13.6
15
*
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
5.6
13.6
39
72
C50.99
ICD-10 Finland
Breast, unspecified
+∞
13.6
13
*
ZX095
NOMESCO Finland
Combined chemoradiotherapy
+∞
13.6
13
*
WF004
NOMESCO Finland
Palliative radiotherapy
+∞
13.6
13
*
X76
ICPC
Malignant neoplasm breast female
+∞
13.6
13
*
8500/3-C50.4
ICD-O-3
Infiltrating duct carcinoma, NOS, of upper-outer quadrant of breast
+∞
13.6
13
*
ZXE00
NOMESCO Finland
One hour or less
1.8
13.5
336
2274
JN4KR
NOMESCO Finland
Whole body very extensive metabolic PET with CT
34.6
13.5
17
5
K02.1
ICD-10 Finland
Caries of dentine
1.7
13.5
472
3541
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
26.2
13.4
18
7
J01MA12
ATC
levofloxacin; systemic
2.1
12.7
155
810
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.8
12.5
290
1908
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
+∞
12.5
12
*
KEC01
NOMESCO Finland
Percutaneous endoscopic radical prostatectomy
+∞
12.5
12
*
A02BC05
ATC
esomeprazole; systemic
1.7
12.4
357
2509
L02BA01
ATC
tamoxifen; oral
38.1
12.2
15
*
JN4AD
NOMESCO Finland
Body CT examination
4.7
12.2
41
91
NK6AN
NOMESCO Finland
Total body bone isotope imaging
27.1
12.1
16
6
ZXE10
NOMESCO Finland
More than one and less than three hours
1.7
12.1
297
1989
HA4AT
NOMESCO Finland
Labeling mammary gland pathology with ultrasound guidance
21.6
12.0
17
8
N05CF01
ATC
zopiclone; oral
1.8
12.0
281
1852
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.9
11.9
197
1156
J02AC01
ATC
fluconazole; systemic
1.7
11.9
328
2270
QAE99
NOMESCO Finland
Other excision or repair surgery of skin and subcutaneous tissue in head and neck
8.5
11.8
25
30
K13.79
ICD-10 Finland
Change in the oral mucosa UNS
5.1
11.7
36
73
ZX120
NOMESCO Finland
Intravenous
2.8
11.6
75
281
UJF30
NOMESCO Finland
Ileoscopy through colon
2.5
11.5
94
403
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
+∞
11.5
11
*
EDB00
NOMESCO Finland
Partial excision of mandible
+∞
11.5
11
*
R4190
NOMESCO Finland
Nutritional therapy
5.5
11.4
33
62
ZXC10
NOMESCO Finland
Use of laser
4.7
11.2
37
81
WZB00
NOMESCO Finland
Telephone receipt or other advice
1.8
11.2
239
1522
UGC12
NOMESCO Finland
Flexible bronchoscopy
2.9
11.2
68
245
L03AA02
ATC
filgrastim; parenteral
43.9
10.9
13
*
ZXE20
NOMESCO Finland
More than three and less than five hours
2.2
10.9
111
532
N05BA04
ATC
oxazepam; oral
1.8
10.8
217
1353
YA1AD
NOMESCO Finland
CT examination of head and neck for dose design of radiotherapy
60.7
10.6
12
*
D10.9
ICD-10 Finland
Benign neoplasm: Pharynx, unspecified
111.3
10.4
11
*
8090/3-C44.5
ICD-O-3
Basal cell carcinoma, NOS, of skin of trunk
+∞
10.4
10
*
HAB50
NOMESCO Finland
Partial excision of mammary gland with reconstructive operation
+∞
10.4
10
*
PJD51
NOMESCO Finland
Block dissection of cervical lymph nodes
+∞
10.4
10
*
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
+∞
10.4
10
*
L03AA14
ATC
lipegfilgrastim; parenteral
+∞
10.4
10
*
EB1AA
NOMESCO Finland
Tooth X-ray examination
1.6
10.4
450
3478
D38.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung
12.2
10.4
18
15
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.9
10.2
169
986
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
6.3
10.2
26
42
K13.78
ICD-10 Finland
Other change in the oral mucosa
4.9
10.2
32
67
S29
ICPC
Skin symptom/complaint other
1.9
10.0
150
844
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.7
9.9
260
1754
UJF32
NOMESCO Finland
Coloscopy
1.8
9.8
214
1364
SDA02
NOMESCO Finland
Parodonthologic therapy
1.7
9.8
271
1854
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
2.6
9.7
73
301
N06AX11
ATC
mirtazapine; oral
1.7
9.7
272
1864
SAA01
NOMESCO Finland
Simple examination of mouth
1.6
9.7
581
4829
EN1AD
NOMESCO Finland
CT examination of mouth and soft tissues of neck
11.5
9.6
17
15
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.2
9.6
100
487
Z3231
NOMESCO Finland
Registered nurse
1.7
9.4
221
1438
D05.1
ICD-10 Finland
Intraductal carcinoma in situ
101.1
9.4
10
*
L02AE02
ATC
leuprorelin; implant, parenteral
17.8
9.4
14
8
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
+∞
9.4
9
*
ZX080
NOMESCO Finland
Image guided radiotherapy
+∞
9.4
9
*
C50.82
ICD-10 Finland
Overall malignant tumor of the mammary gland, lobular tumor
+∞
9.4
9
*
C77.0
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph nodes of head, face and neck
+∞
9.4
9
*
C50.90
ICD-10 Finland
Malignant tumor in other or unspecified location in mammary gland without histology
+∞
9.4
9
*
JN6AD
NOMESCO Finland
CT of torso and neck
22.0
9.4
13
6
TPH04
NOMESCO Finland
Cathetrisation of vein
1.8
9.4
164
976
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
3.1
9.3
49
163
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
2.5
9.1
72
306
WZC05
NOMESCO Finland
Specialty-specific consultation based on referral by dentist or doctor
3.0
9.1
52
181
Z3226
NOMESCO Finland
Physiotherapist
1.9
9.1
153
896
K13.28
ICD-10 Finland
Other leukoplakia or disorder of epithelium of the palate or tongue
15.8
9.0
14
9
Z2446
NOMESCO Finland
Social worker
2.7
9.0
60
229
WX105
NOMESCO Finland
Surface analgesia on skin or mucosa
2.2
9.0
89
421
B01AB05
ATC
enoxaparin; parenteral
1.7
8.9
223
1480
J01FA10
ATC
azithromycin; systemic
1.5
8.8
463
3692
A06AC01
ATC
ispaghula (psylla seeds); oral
1.7
8.8
211
1380
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
1.5
8.8
394
3026
ZXA00
NOMESCO Finland
Right side
1.7
8.8
225
1497
EBA15
NOMESCO Finland
Extraction of large number of teeth
3.5
8.8
40
119
J01MA02
ATC
ciprofloxacin; systemic
1.6
8.8
305
2203
Y77
ICPC
Malignant neoplasm prostate
50.5
8.7
10
*
SFA10
NOMESCO Finland
Fillning on one surface of tooth
1.5
8.6
427
3354
R22.0
ICD-10 Finland
Localized swelling, mass and lump, head
3.8
8.5
35
96
A01AB04
ATC
amphotericin B; local oral
2.9
8.5
51
185
PJD41
NOMESCO Finland
Excision of cervical lymph nodes
20.2
8.5
12
6
HA1CG
NOMESCO Finland
Extensive MRI examination of mammary gland with high intensity magnet
20.2
8.5
12
6
SAA02
NOMESCO Finland
Basic examination of mouth
1.5
8.5
509
4169
N02AX02
ATC
tramadol; systemic, rectal
1.5
8.4
347
2607
HA6AA
NOMESCO Finland
Extra corporeal mammography of operated mammary gland
12.9
8.4
14
11
EBA10
NOMESCO Finland
Surgical removal of tooth
2.1
8.4
92
458
Z01.9
ICD-10 Finland
Special examination, unspecified
2.7
8.4
57
223
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
1.9
8.3
121
670
C02.0
ICD-10 Finland
Malignant neoplasm: Dorsal surface of tongue
+∞
8.3
8
*
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
+∞
8.3
8
*
4399
FHL
Other measure in this category
+∞
8.3
8
*
4392
FHL
Tongue and / or Mouth resection or excision
+∞
8.3
8
*
C50.42
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, lobular tumor
+∞
8.3
8
*
WB203
NOMESCO Finland
Simple adjuvant hormone therapy of malignancy
+∞
8.3
8
*
C03.1
ICD-10 Finland
Malignant neoplasm: Lower gum
+∞
8.3
8
*
C50.4
ICD-10 Finland
Malignant neoplasm: Upper-outer quadrant of breast
+∞
8.3
8
*
C02.1
ICD-10 Finland
Malignant neoplasm: Border of tongue
+∞
8.3
8
*
C20.91
ICD-10 Finland
Malignant tumor of the rectum invasive carcinoma
+∞
8.3
8
*
C50.40
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, no histological veryfication
+∞
8.3
8
*
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
2.0
8.3
100
518
EBB10
NOMESCO Finland
Insertion of dental implant
6.6
8.2
20
31
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.5
8.0
391
3040
K04.5
ICD-10 Finland
Chronic apical periodontitis
1.7
8.0
206
1373
N03AX16
ATC
pregabalin; oral
1.7
7.9
191
1248
ZXC96
NOMESCO Finland
Robot assisted procedure
13.2
7.9
13
10
D10.39
ICD-10 Finland
Benign tumor in other or unspecified part of oral cavity UNS
13.2
7.9
13
10
R04.2
ICD-10 Finland
Haemoptysis
3.4
7.8
36
109
ZXE40
NOMESCO Finland
More than seven and less than nine hours
4.2
7.7
28
69
EP1CM
NOMESCO Finland
Extensive MRI examination of soft tissue of neck with 3 Tesla magnet
45.4
7.7
9
*
R01AD08
ATC
fluticasone; nasal
1.6
7.7
227
1563
SDA03
NOMESCO Finland
Demanding parodonthologic therapy
1.5
7.7
298
2195
D23.3
ICD-10 Finland
Benign neoplasm: Skin of other and unspecified parts of face
4.3
7.6
27
65
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.8
7.6
133
787
ZXD30
NOMESCO Finland
Difficulties in perfomrming procedure
3.1
7.6
39
128
KE1AT
NOMESCO Finland
Biopsy of prostata with ultrasoudnguidance
4.4
7.6
26
61
A02BC03
ATC
lansoprazole; oral
1.6
7.6
248
1755
SBA00
NOMESCO Finland
Microbiological examinations
3.5
7.6
33
96
EAA10
NOMESCO Finland
Excision of lesion of lip
10.1
7.5
14
14
WX002
NOMESCO Finland
Sedation and analgesia
1.7
7.5
167
1065
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
1.9
7.5
104
569
R50.9
ICD-10 Finland
Fever, unspecified
2.0
7.4
99
530
C50
ICD-10 Finland
Malignant neoplasm of breast
80.8
7.4
8
*
YA1VG
NOMESCO Finland
MRI examination of head and neck with high intesity magnet for dose design of radiotherapy
80.8
7.4
8
*
K14.88
ICD-10 Finland
Other diseases of tongue
80.8
7.4
8
*
K05.31
ICD-10 Finland
Periodontitis pronounced
2.0
7.4
91
473
R01AD09
ATC
mometasone; nasal
1.5
7.4
350
2692
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
2.1
7.4
83
418
D02
ICPC
Abdominal pain epigastric
2.5
7.4
55
228
F32.9
ICD-10 Finland
Depressive episode, unspecified
2.0
7.3
100
540
C50.91
ICD-10 Finland
Malignant tumor in another specified localization in ductal mammary gland
+∞
7.3
7
*
C90.0
ICD-10 Finland
Multiple myeloma
+∞
7.3
7
*
C02.2
ICD-10 Finland
Malignant neoplasm: Ventral surface of tongue
+∞
7.3
7
*
GDC01
NOMESCO Finland
Thoracoscopic lobectomy of lung
+∞
7.3
7
*
PJ5AQ
NOMESCO Finland
Sentinell lymphnode SPECT with low dose CT
+∞
7.3
7
*
128
Kela drug reimbursment
Cancers of female genital organs
+∞
7.3
7
*
C34.12
ICD-10 Finland
Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma
+∞
7.3
7
*
EBB15
NOMESCO Finland
Insertion of dental implant abutment
9.5
7.3
14
15
E0000UV
ATC
NA
1.5
7.2
309
2321
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.8
7.2
139
848
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
2.5
7.2
54
225
EP1BG
NOMESCO Finland
MRI examination of soft tissue of neck with high intesity magnet
30.3
7.2
9
*
OAB73
NOMESCO Finland
Prevention and treatment of malnutrition
20.2
7.1
10
5
D70.82
ICD-10 Finland
Drug-induced neutropenia
20.2
7.1
10
5
WX000
NOMESCO Finland
Monitoring vital functions without anesthesy
3.2
7.1
35
112
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
2.7
7.0
45
170
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
2.0
7.0
90
480
D07AC13
ATC
mometasone; topical
1.5
6.9
239
1707
R03AC13
ATC
formoterol; inhalant
2.7
6.9
46
179
L14
ICPC
Leg/thigh symptom/complaint
2.2
6.9
67
315
UJD02
NOMESCO Finland
Gastroscopy
2.6
6.8
48
192
M01AE03
ATC
ketoprofen; systemic, rectal
1.5
6.8
312
2370
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.5
6.8
334
2572
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
2.2
6.8
67
317
P01AB01
ATC
metronidazole; oral, rectal
1.5
6.8
302
2282
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
6.2
6.8
17
28
M05BX04
ATC
denosumab; parenteral
2.9
6.8
39
138
EJB00
NOMESCO Finland
Excision of ranula
40.4
6.8
8
*
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
40.4
6.8
8
*
Z01.2
ICD-10 Finland
Dental examination
1.5
6.8
312
2372
A02BC01
ATC
omeprazole; systemic
1.5
6.7
229
1628
R53
ICD-10 Finland
Malaise and fatigue
1.7
6.7
158
1021
B37.0
ICD-10 Finland
Candidal stomatitis
7.2
6.7
15
21
R03BA05
ATC
fluticasone; inhalant
1.7
6.7
144
908
R03BB04
ATC
tiotropium bromide; inhalant
2.0
6.7
82
429
B37.09
ICD-10 Finland
Unspecified candidal stomatitis
6.5
6.7
16
25
SFA30
NOMESCO Finland
Filling on tree or more surfaces of tooth
1.5
6.6
328
2529
WW500
NOMESCO Finland
Blood transfusion
3.9
6.6
25
65
A06AD11
ATC
lactulose; oral
1.8
6.6
114
672
JN3BD
NOMESCO Finland
Extensive abdominal CT
2.0
6.6
79
409
ZZR00
NOMESCO Finland
Flap of skin
10.1
6.5
12
12
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
2.7
6.5
43
167
H02AB04
ATC
methylprednisolone; systemic
1.8
6.5
122
739
J01CE02
ATC
phenoxymethylpenicillin; oral
1.4
6.5
546
4667
UKC02
NOMESCO Finland
Cystoscopy
1.8
6.5
111
651
TDW99
NOMESCO Finland
Other minor procedure in surgery of ear, nose and larynx
3.2
6.4
32
104
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
4.7
6.4
20
43
D10.2
ICD-10 Finland
Benign neoplasm: Floor of mouth
70.3
6.4
7
*
D37.09
ICD-10 Finland
Lip, oral cavity and pharynx
70.3
6.4
7
*
G04CA02
ATC
tamsulosin; oral
1.6
6.3
153
998
Z50.5
ICD-10 Finland
Speech therapy
6.0
6.3
16
27
XF400
NOMESCO Finland
ECG with 12 standard connections
1.7
6.3
128
794
K13.20
ICD-10 Finland
Idiopathic leukoplakia
9.3
6.3
12
13
R60.0
ICD-10 Finland
Localized oedema
1.9
6.3
85
462
D48.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Skin
2.8
6.3
38
141
8500/2-C50.9
ICD-O-3
Intraductal carcinoma, noninfiltrating, NOS, of breast, NOS
+∞
6.3
6
*
C43.52
ICD-10 Finland
Malignant melanoma on the torso: 'superficial spreading' type
+∞
6.3
6
*
XX1XN
NOMESCO Finland
Other isotope examination
+∞
6.3
6
*
L02BB03
ATC
bicalutamide; oral
+∞
6.3
6
*
YX9BD
NOMESCO Finland
Other extensive CT eamination for dose design of radiotherapy
+∞
6.3
6
*
EJC99
NOMESCO Finland
Other reconstructive operations on tongue and floor of mouth
+∞
6.3
6
*
C67.9
ICD-10 Finland
Malignant neoplasm: Bladder, unspecified
+∞
6.3
6
*
C04.1
ICD-10 Finland
Malignant neoplasm: Lateral floor of mouth
+∞
6.3
6
*
HAC25
NOMESCO Finland
Radical mastectomy
+∞
6.3
6
*
C54.11
ICD-10 Finland
Adenocarcinoma of the endometrium
+∞
6.3
6
*
C02.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of tongue
+∞
6.3
6
*
C50.49
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, other or undeterminated histology
+∞
6.3
6
*
8140/3-C20.9
ICD-O-3
Adenocarcinoma, NOS, of rectum, NOS
+∞
6.3
6
*
8520/3-C50.9
ICD-O-3
Lobular carcinoma, NOS, of breast, NOS
+∞
6.3
6
*
C50.21
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland,ductal tumor
+∞
6.3
6
*
SFA20
NOMESCO Finland
Filling on two surfaces of tooth
1.4
6.2
447
3692
ZXE30
NOMESCO Finland
More than five and less than seven hours
2.8
6.2
37
135
R06AE07
ATC
cetirizine; oral
1.5
6.2
329
2562
R52.0
ICD-10 Finland
Acute pain
3.4
6.2
27
80
SDE03
NOMESCO Finland
Periodontal treatment by dental hygienist, extensive
1.6
6.1
189
1310
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
1.6
6.1
146
948
R07.4
ICD-10 Finland
Chest pain, unspecified
1.5
6.1
223
1607
M01AE01
ATC
ibuprofen; systemic, rectal
1.6
6.1
743
6805
B37.08
ICD-10 Finland
Other candidal stomatitis
8.7
6.1
12
14
SCA01
NOMESCO Finland
Simple analysis and advice of nutrition with regard to dentistry
1.5
6.1
203
1434
K12.10
ICD-10 Finland
Stomatitis NOS
10.1
6.0
11
11
X59
ICD-10 Finland
Exposure to unspecified factor
1.6
6.0
145
942
B01AB10
ATC
tinzaparin; parenteral
2.6
6.0
40
157

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(40768804) Tissue Pathology biopsy report
562
2490
3.92
98.08
2.7
1.7
—
—
—
0
0
(4035726)
147
233
7.24
91.22
1.6
1.2
—
—
—
0
0
(3002256) Pathology report gross observation
176
577
3.50
44.21
1.3
1.1
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
583
3698
2.41
39.12
7.4
3.8
umol/l
11.2
11.5
0.26
545
3470
(3013650) Neutrophils [#/volume] in Blood by Automated count
607
4191
2.17
29.65
11.5
6.4
e9/l
4.1
4.2
0.48
534
3642
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
772
5893
2.43
29.20
9.9
5.4
u/l
78.2
75.5
1.54
728
5455
(3024561) Albumin [Mass/volume] in Serum or Plasma
490
3130
2.12
29.19
5.8
3.7
g/l
35.4
35.8
0.77
455
2890
(3022096) Basophils/100 leukocytes in Blood
514
3365
2.10
28.44
7.5
5.6
%
0.7
0.7
0.53
477
3120
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
120
410
3.19
27.66
3.9
1.4
ug/l
8.2
3.5
0.60
102
309
(42870588) Differential panel, method unspecified - Blood
403
2431
2.11
27.48
7.1
5.6
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
523
3478
2.07
27.37
7.5
5.6
%
2.7
3.0
1.42
484
3216
(3019069) Monocytes/100 leukocytes in Blood
524
3493
2.07
27.18
7.8
5.9
%
8.8
8.6
0.61
487
3250
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
546
3720
2.05
26.38
8.0
5.5
mmol/l
1.2
1.2
0.08
461
3160
(3002030) Lymphocytes/100 leukocytes in Blood
530
3573
2.05
26.36
7.7
5.7
%
26.5
28.1
2.54
491
3316
(3033658) Prothrombin time (PT) actual/Normal
318
1778
2.16
26.18
4.4
3.4
%
92.1
89.2
1.13
312
1729
(3023368) Bacteria identified in Blood by Culture
326
1850
2.14
25.75
5.1
3.9
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
565
3924
2.03
25.56
7.1
5.6
e9/l
0.2
0.2
0.20
495
3448
(3001604) Monocytes [#/volume] in Blood
547
3768
2.01
25.18
7.0
5.4
e9/l
0.6
0.6
0.34
471
3258
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
503
3379
2.00
24.71
7.0
5.1
mmol/l
1.2
1.2
0.23
448
2996
(3006315) Basophils [#/volume] in Blood
547
3785
2.00
24.66
7.0
5.4
e9/l
0.0
0.0
0.82
471
3276
(3018010) Neutrophils/100 leukocytes in Blood
520
3540
1.99
24.52
7.4
5.5
%
57.9
57.1
0.72
483
3297
(3019198) Lymphocytes [#/volume] in Blood
551
3866
1.96
23.37
7.1
5.4
e9/l
1.8
1.9
0.34
483
3402
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
170
766
2.47
22.99
3.1
2.2
umol/l
9.0
6.8
0.59
143
661
(3012095) Magnesium [Moles/volume] in Serum or Plasma
214
1076
2.26
22.51
5.0
2.5
mmol/l
0.8
0.8
3.25
200
996
(3002582) Erythrocytes [#/volume] in Urine
356
2199
1.97
21.52
3.4
3.0
e6/l
236.7
84.3
0.34
258
1692
(40758558) Short blood count panel - Blood
301
1758
2.03
21.31
8.6
4.8
—
—
—
0
0
(3018418) pH of Serum or Plasma
348
2142
1.97
21.18
5.0
3.2
ph
7.4
7.4
0.01
56
354
(3031040) Bacteria [#/volume] in Urine by Automated count
662
5045
1.95
20.86
5.6
4.2
e6/l
2923.3
2459.0
0.08
14
78
(3015377) Calcium [Moles/volume] in Serum or Plasma
380
2421
1.93
20.80
4.8
2.0
mmol/l
2.4
2.4
0.53
327
2016
(3030467) Casts [#/volume] in Urine by Automated count
331
2013
1.97
20.79
3.4
2.9
e6/l
0.3
0.4
0.98
236
1512
(40768795) Lymph node Pathology biopsy report
22
20
11.23
20.72
1.2
1.0
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
400
2613
1.89
20.12
4.2
3.4
e6/l
48.1
113.3
2.17
280
1831
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
216
1140
2.15
19.91
2.9
2.7
e6/l
1.4
2.7
2.53
116
598
(3044640) Blood type and Crossmatch panel - Blood
342
2137
1.92
19.60
3.2
2.2
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
43
91
4.90
19.31
2.3
1.3
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
282
1660
1.98
19.22
2.9
2.1
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
115
474
2.61
18.58
2.0
1.5
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
471
3315
1.81
18.06
4.5
3.7
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
45
105
4.44
17.97
1.2
1.2
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
314
1953
1.89
17.95
3.4
2.8
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
603
4579
1.82
17.81
5.7
4.2
mmol/l
6.7
6.8
0.20
576
4253
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
143
667
2.34
17.67
2.6
2.1
u/l
32.7
42.1
0.69
120
559
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
222
1248
2.01
17.00
2.8
2.5
e6/l
0.7
1.2
3.47
123
706
(3037467) Urinalysis macro (dipstick) panel - Urine
680
5402
1.83
16.80
5.3
4.1
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
145
700
2.26
16.48
5.0
3.1
u/l
245.8
237.6
0.16
140
659
(3032080) INR in Blood by Coagulation assay
431
3030
1.75
15.99
9.7
9.6
inr
1.2
1.3
2.06
113
870
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
124
569
2.35
15.85
2.9
2.0
g/l
0.2
0.2
1.77
115
513
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
18
18
10.17
15.84
3.0
2.3
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
359
2404
1.78
15.72
4.0
2.7
u/l
32.9
32.6
0.04
331
2289
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
91
367
2.63
15.32
7.5
8.8
mmol/l
25.0
24.5
1.03
86
341
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
172
920
2.05
14.97
2.6
2.5
%
21.4
23.9
1.24
153
784
(3000494) Fungus identified in Specimen by Culture
170
910
2.05
14.75
1.6
1.4
—
—
—
0
0
(3014111) Lactate [Moles/volume] in Serum or Plasma
129
633
2.19
14.00
6.8
6.1
mmol/l
1.3
1.4
0.50
122
610
(40768797) Stomach Pathology biopsy report
196
1122
1.93
13.99
1.2
1.2
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
178
1014
1.92
12.81
2.5
2.4
g/l
2.3
2.3
0.07
165
940
(3026782) Osmolality of Urine
229
1418
1.80
12.64
3.2
2.4
mosm/kgh2o
531.9
547.2
0.46
185
1188
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
888
7935
2.20
12.62
22.2
12.1
mg/l
27.5
22.5
3.11
735
6067
(3013707) Erythrocyte sedimentation rate by Westergren method
716
5984
1.72
12.59
4.7
4.1
mm/h
13.1
11.6
1.79
651
5512
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
223
1380
1.80
12.30
4.0
2.1
mmol/l
2.5
2.4
1.88
197
1182
(3018677) aPTT in Platelet poor plasma by Coagulation assay
189
1122
1.85
11.91
1.9
1.9
s
29.8
29.7
0.12
183
1082
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
345
2429
1.65
11.80
2.7
2.3
u/l
55.8
58.4
0.44
310
2229
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
15
5
30.42
11.66
3.5
1.0
u/ml
21.2
14.8
—
15
5
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
195
1183
1.81
11.42
2.1
1.8
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
239
1540
1.73
11.36
2.7
2.3
e6/l
5.5
6.4
0.39
197
1339
(3042936) Bacteria identified in Isolate by Culture
178
1052
1.84
11.34
2.4
1.9
—
—
—
0
0
(3022145) Colonoscopy Study observation
140
767
1.96
11.23
1.4
1.3
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
239
1555
1.71
10.92
3.8
3.8
ng/l
379.8
531.8
0.36
185
1208
(3022948) Iron [Moles/volume] in Serum or Plasma
185
1127
1.79
10.63
2.6
2.3
umol/l
12.5
13.6
1.26
169
1028
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
50
179
2.89
10.57
3.1
3.1
mg/l
1.3
1.6
1.34
45
164
(40768793) Breast Pathology biopsy report
26
60
4.42
10.56
1.5
1.2
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
126
685
1.96
10.31
2.9
1.8
nmol/l
380.5
365.6
0.32
108
622
(3001122) Ferritin [Mass/volume] in Serum or Plasma
430
3277
1.55
10.14
3.2
2.7
ug/l
132.0
122.3
0.34
398
3001
(3020779) Urea [Moles/volume] in Serum or Plasma
116
617
2.00
10.10
7.3
6.4
mmol/l
8.5
9.7
1.25
110
586
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
278
1916
1.63
10.06
2.7
2.2
mg/l
2.7
3.0
0.86
233
1615
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
443
3406
1.55
9.99
2.3
2.0
pmol/l
95.7
96.3
0.09
200
1716
(3021589) Normoblasts [#/volume] in Blood
437
3359
1.54
9.81
12.1
8.1
e9/l
0.0
0.0
0.30
357
2745
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
144
838
1.84
9.56
2.0
1.7
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
426
3272
1.53
9.51
2.6
2.3
nmol/l
79.4
78.3
0.31
375
2884
(3019550) Sodium [Moles/volume] in Serum or Plasma
910
8370
2.13
9.41
24.0
14.4
mmol/l
139.4
139.8
4.29
891
8142
(3000991) Gas panel - Venous blood
111
596
1.97
9.40
8.3
7.4
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
73
339
2.25
9.04
3.4
3.5
mmol/l
25.4
24.4
1.79
67
301
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
717
6200
1.57
8.96
4.6
3.9
pmol/l
14.8
14.8
0.26
647
5627
(3052851) Hemolysis interference index of Serum or Plasma
52
208
2.58
8.93
2.8
3.0
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
27
73
3.77
8.93
5.0
3.4
%
1.0
1.2
0.14
21
61
(3023103) Potassium [Moles/volume] in Serum or Plasma
910
8396
2.09
8.91
24.4
14.5
mmol/l
3.9
4.0
3.02
888
8152
(3008295) Osmolality of Serum or Plasma
26
69
3.84
8.83
1.4
1.4
mosm/kgh2o
284.5
274.1
1.47
19
50
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
43
159
2.78
8.61
3.8
1.9
u/ml
256.4
85.0
0.51
38
130
(3003458) Phosphate [Moles/volume] in Serum or Plasma
155
952
1.75
8.55
7.1
4.8
mmol/l
1.0
1.0
0.04
150
860
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
14
22
6.44
8.54
4.7
4.1
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
92
480
2.01
8.45
2.4
2.3
nmol/l
13.0
14.5
0.89
82
430
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
140
842
1.77
8.30
2.0
1.8
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
268
1907
1.56
8.23
1.8
1.5
nmol/l
22.6
21.1
0.88
220
1602
(3021879) Hepatitis B virus core Ab [Presence] in Serum
84
428
2.05
8.23
1.4
1.4
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
13
9
14.61
8.21
1.2
1.1
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
40
147
2.79
8.11
1.4
1.3
u/l
12.9
8.5
0.94
35
118
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
24
64
3.82
8.10
1.2
1.2
u/l
52.7
55.1
0.09
18
46
(3014576) Chloride [Moles/volume] in Serum or Plasma
149
920
1.73
8.05
7.7
5.8
mmol/l
104.3
104.3
0.01
142
895
(3049717) Cytology report of Urine Cyto stain
53
226
2.42
7.99
2.6
1.7
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
240
1677
1.57
7.95
1.9
1.7
mg/l
1.1
1.1
0.06
184
1259
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
86
448
2.01
7.93
2.0
1.6
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
164
1052
1.67
7.68
25.3
25.0
inr
1.3
1.4
0.44
23
144
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
46
187
2.53
7.67
2.3
2.7
u/ml
0.3
0.4
0.12
20
113
(3017143) Hepatitis C virus Ab [Presence] in Serum
119
704
1.79
7.44
1.7
1.5
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
16
33
4.91
7.42
1.0
1.3
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
135
831
1.72
7.36
2.9
2.3
%
1.8
1.8
0.14
116
733
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
32
110
2.97
7.33
1.2
1.3
—
—
—
0
0
(3019225) pH of Specimen
125
755
1.75
7.28
4.9
3.4
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
330
2515
1.47
7.13
2.2
2.2
u/l
185.4
253.5
0.85
311
2375
(3002032) Base excess in Venous blood by calculation
118
706
1.76
7.10
3.8
3.1
mmol/l
2.6
2.0
0.81
106
572
(3023520) Reticulocytes [#/volume] in Blood
105
608
1.81
7.05
2.8
2.4
e9/l
74.0
69.0
0.72
71
467
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
79
418
1.97
6.99
2.7
3.0
pmol/l
4.5
4.5
0.03
69
357
(3021601) Nitrite [Presence] in Urine by Test strip
475
3887
1.43
6.96
5.9
4.9
estimate
0.0
0.0
0.00
84
665
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
834
7611
1.62
6.92
20.3
10.9
ml/min/173m2
80.0
79.5
0.30
708
6117
(3007164) IgA [Mass/volume] in Serum or Plasma
209
1459
1.55
6.85
1.5
1.3
g/l
2.4
2.6
0.39
112
865
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
175
1173
1.60
6.84
1.5
1.5
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
477
3917
1.42
6.80
4.2
3.6
estimate
0.0
0.0
0.80
81
643
(3008757) Leukocyte morphology finding [Identifier] in Blood
21
58
3.68
6.77
6.2
4.0
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
141
899
1.66
6.73
2.4
2.2
ug/g
153.8
143.8
0.08
107
715
(3003396) Base excess in Arterial blood by calculation
136
859
1.68
6.73
7.1
6.7
mmol/l
1.0
1.3
0.31
113
669
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
121
742
1.72
6.68
3.5
2.9
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
600
5144
1.43
6.64
3.9
3.0
u/l
51.9
46.7
0.62
548
4767
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
820
7479
1.57
6.53
5.7
4.6
mu/l
1.9
2.1
0.43
745
6822
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
556
4713
1.41
6.50
3.0
2.7
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
469
3870
1.40
6.35
4.2
3.6
estimate
0.0
0.0
0.00
82
665
(3007853) Bacteria identified in Skin by Aerobe culture
130
824
1.67
6.34
2.0
1.7
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
733
6544
1.47
6.34
25.9
14.6
%
13.8
13.6
1.97
722
6380
(40768800) Prostate Pathology biopsy report
16
38
4.26
6.30
1.1
1.1
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
61
306
2.06
6.27
1.8
1.6
g/l
1.6
1.5
0.45
51
264
(3027801) Oxygen [Partial pressure] in Arterial blood
134
859
1.65
6.26
7.2
6.7
kpa
12.5
11.7
0.85
126
830
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
134
859
1.65
6.26
7.2
6.7
kpa
5.2
5.1
0.42
127
829
(40768443) Skin Pathology biopsy report
59
293
2.08
6.23
1.4
1.2
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
299
2292
1.44
6.09
3.7
3.0
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
28
100
2.85
6.03
1.6
1.4
—
—
—
0
0
(3044889) 12 lead EKG panel
650
5706
1.41
5.93
4.2
3.8
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
25
85
2.99
5.87
3.0
3.5
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
36
149
2.47
5.84
3.1
1.3
—
—
—
0
0
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
24
80
3.05
5.83
2.0
2.0
u/ml
68.4
41.2
0.31
24
74
(3000492) Spirometry study
115
723
1.67
5.79
1.7
1.5
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
791
7213
1.49
5.75
23.6
13.3
%
39.5
40.0
0.78
580
5022
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
913
8610
1.82
5.74
13.9
8.9
u/l
25.8
26.2
0.43
885
8246
(3000570) Elastase.pancreatic [Mass/mass] in Stool
44
203
2.22
5.61
1.5
1.4
ug/g
253.6
312.0
1.14
26
122
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
19
56
3.44
5.60
1.9
1.5
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
30
116
2.64
5.59
1.2
1.4
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
24
83
2.94
5.49
3.1
2.4
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
891
8363
1.68
5.47
19.1
11.7
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
152
1037
1.55
5.46
1.9
1.7
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
306
2394
1.40
5.45
3.0
2.9
ng/l
1257.9
1276.4
0.03
266
2019
(3003694) ABO and Rh group [Type] in Blood
253
1916
1.43
5.41
1.5
1.3
—
—
—
0
0
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
44
207
2.18
5.36
4.4
1.4
mg/l
25.8
60.2
0.71
30
170
(3011397) Hemoglobin [Presence] in Urine by Test strip
246
1865
1.43
5.21
3.7
3.6
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
20
64
3.17
5.21
1.4
1.6
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
34
145
2.39
5.20
1.6
1.4
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
34
145
2.39
5.20
1.6
1.4
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
209
1539
1.45
5.18
1.9
1.7
nmol/l
1151.6
1184.6
0.17
144
1158
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
34
146
2.38
5.13
1.5
1.5
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
13
31
4.24
5.10
1.3
1.2
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
127
847
1.57
5.03
1.5
1.5
—
—
—
0
0
(3034860) Kappa light chains.free [Mass/volume] in Serum
43
206
2.14
5.03
4.4
1.4
mg/l
90.4
43.9
0.36
30
169
(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma
11
23
4.83
5.02
2.0
1.5
ug/l
0.2
0.4
—
6
13
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
46
227
2.08
4.99
2.5
3.1
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
13
32
4.10
4.90
2.1
2.3
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
84
509
1.71
4.86
2.4
2.4
g/l
9.7
10.8
1.72
76
469
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
38
176
2.21
4.83
1.5
1.7
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
91
566
1.67
4.78
3.6
4.0
%
0.9
0.8
0.21
33
118
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
225
1703
1.42
4.77
1.3
1.2
u/ml
0.7
1.7
2.32
58
468
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
32
140
2.33
4.65
1.6
1.5
—
—
—
0
0
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
20
69
2.94
4.62
3.9
1.6
u/ml
441.0
61.2
0.40
20
64
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
21
75
2.84
4.57
1.1
1.1
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
22
81
2.76
4.53
1.6
1.1
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
40
195
2.10
4.50
1.5
1.2
—
—
—
0
0
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
37
176
2.15
4.43
1.9
2.4
g/l
3.7
3.6
0.18
37
168
(3013139) Helicobacter pylori Ag [Presence] in Stool
85
531
1.66
4.41
1.4
1.3
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
131
912
1.50
4.28
2.4
1.7
%
1.6
1.5
0.25
110
794
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
12
31
3.91
4.26
1.3
1.2
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
29
127
2.32
4.23
1.6
1.2
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
13
36
3.65
4.21
1.0
1.0
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
13
36
3.65
4.21
1.0
1.0
—
—
—
0
0
(3012501) Base excess in Blood by calculation
30
134
2.28
4.19
4.4
4.3
mmol/l
2.9
2.9
0.00
20
92
(3017732) Neutrophils [#/volume] in Blood
82
515
1.65
4.18
3.3
3.0
e9/l
3.9
4.2
0.36
56
392
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
40
202
2.02
4.12
1.5
1.2
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
85
541
1.63
4.11
3.6
4.1
%
0.0
0.0
1.61
31
105
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
31
142
2.22
4.09
1.6
1.2
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
28
124
2.29
3.99
1.7
1.3
mmol/l
57.0
62.0
0.22
21
102
(3024522) Salmonella sp identified in Specimen by Organism specific culture
21
81
2.63
3.99
1.7
1.1
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
21
81
2.63
3.99
1.7
1.1
—
—
—
0
0
(3016502) Oxygen saturation in Arterial blood
112
767
1.52
3.96
7.8
7.0
%
95.7
95.3
0.22
107
747
(3017354) Segmented neutrophils/100 leukocytes in Blood
15
48
3.16
3.94
7.1
3.8
%
54.4
50.9
—
9
37
(3024731) MCV [Entitic volume]
933
8969
1.75
3.89
30.7
17.8
fl
91.3
91.1
0.72
921
8807
(3035941) MCH [Entitic mass]
933
8970
1.75
3.88
30.6
17.7
pg
30.4
30.4
0.03
921
8807
(3035637) Corticotropin [Mass/volume] in Plasma
18
65
2.80
3.87
1.1
1.7
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
933
8971
1.74
3.86
30.8
17.8
e12/l
4.4
4.5
5.75
911
8685
(3010813) Leukocytes [#/volume] in Blood
933
8973
1.74
3.83
30.9
17.9
e9/l
6.8
6.7
0.63
911
8688
(3003327) Ova and parasites identified in Stool by Light microscopy
42
222
1.93
3.83
1.7
1.8
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
20
77
2.63
3.82
1.6
1.1
—
—
—
0
0
(3003338) MCHC [Mass/volume]
737
6790
1.34
3.81
26.5
16.0
g/l
331.8
332.6
1.58
729
6734
(3000963) Hemoglobin [Mass/volume] in Blood
933
8974
1.74
3.81
31.0
17.9
g/l
133.3
136.6
8.83
921
8812
(3020630) Protein [Mass/volume] in Serum or Plasma
89
584
1.58
3.81
3.9
1.6
g/l
66.1
67.2
0.67
83
525
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
855
8073
1.44
3.76
5.3
4.7
mmol/l
6.0
6.0
0.04
763
7344
(3007461) Platelets [#/volume] in Blood
932
8966
1.72
3.75
30.8
17.8
e9/l
249.6
250.3
0.11
914
8706
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
70
435
1.66
3.73
1.7
1.5
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
20
78
2.60
3.73
1.6
1.1
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
10
25
4.03
3.70
1.4
1.3
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
10
25
4.03
3.70
1.4
1.3
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
59
351
1.72
3.70
2.1
1.8
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
21
85
2.50
3.65
1.4
1.4
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
20
79
2.56
3.65
1.6
1.1
—
—
—
0
0
(3022621) pH of Urine by Test strip
80
518
1.59
3.63
2.8
2.8
—
—
—
0
0
(3013512) EKG study
290
2375
1.31
3.61
4.9
3.8
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
66
408
1.66
3.60
1.9
1.4
g/l
1.1
1.2
0.46
60
378
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
17
62
2.77
3.60
2.0
2.0
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
48
271
1.81
3.59
4.0
1.3
g/l
3.1
3.0
0.26
38
212
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
9
18
5.04
3.37
2.2
1.9
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
10
27
3.73
3.36
1.1
1.1
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
49
285
1.76
3.34
2.0
1.7
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
16
59
2.74
3.33
1.4
1.2
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
77
505
1.57
3.33
3.2
1.4
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
29
143
2.06
3.23
2.6
2.1
u/l
980.2
4225.5
—
8
55
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
35
185
1.92
3.23
1.2
1.4
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
61
381
1.64
3.22
1.2
1.2
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
365
3117
1.27
3.22
4.4
3.7
ng/l
40.0
49.7
0.28
254
2172
(3006922) Hepatitis E virus Ab [Presence] in Serum
12
38
3.18
3.22
1.0
1.1
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
82
550
1.54
3.22
4.6
2.7
mmol/l
1.2
1.2
0.58
70
453
(4010399)
89
610
1.50
3.16
1.4
1.4
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
211
1681
1.32
3.15
4.2
4.1
—
—
—
0
0
(3019230) Fractional oxyhemoglobin in Venous blood
28
138
2.06
3.13
2.1
2.1
%
60.5
62.6
0.17
28
138
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
30
152
2.00
3.12
1.9
1.5
—
—
—
0
0
(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence
14
50
2.83
3.09
1.1
1.4
—
276.7
—
0
6
(1761868) Lipid panel - Serum or Plasma
240
2906
0.77
3.09
3.3
3.0
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
255
2091
1.30
3.08
2.7
2.3
umol/l
2876.3
6545.3
1.07
221
1805
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
6
8
7.54
3.06
1.3
1.5
—
—
—
0
0
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
10
29
3.47
3.05
2.4
1.3
u/l
226.5
197.9
—
10
29
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
307
2582
1.27
3.04
4.5
3.7
ug/l
1.8
1.9
0.28
277
2324
(3002179) Metamyelocytes/100 leukocytes in Blood
78
526
1.52
3.00
3.6
4.0
%
0.5
0.5
0.05
19
93
(3000475) Leukocytes [#/volume] in Synovial fluid
37
205
1.84
2.98
2.0
1.6
e6/l
16325.7
16418.0
0.01
28
155
(3028772) Osteocalcin [Mass/volume] in Serum or Plasma
12
40
3.02
2.98
3.1
2.9
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
48
289
1.69
2.93
3.9
1.3
g/l
3.8
3.9
0.10
38
208
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
48
289
1.69
2.93
4.0
1.3
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
48
289
1.69
2.93
4.0
1.3
g/l
7.2
7.4
0.32
40
216
(3025130) Human papilloma virus identified in Specimen
17
70
2.45
2.89
1.8
1.8
—
—
—
0
0
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
6
9
6.70
2.87
1.0
1.0
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
46
276
1.70
2.85
1.6
1.6
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
76
518
1.51
2.80
3.7
4.2
%
0.0
1.0
0.56
24
97
(1616796) Gas panel - Central venous blood
26
131
2.01
2.77
4.5
3.2
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
32
174
1.87
2.75
2.6
2.7
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
13
48
2.73
2.72
1.6
1.5
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
15
60
2.52
2.71
1.3
1.2
—
—
—
0
0
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
6
10
6.03
2.70
1.0
1.0
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
23
112
2.08
2.69
1.3
1.4
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
26
133
1.98
2.67
2.5
3.4
%
58.3
58.9
0.10
26
133
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
22
106
2.10
2.64
1.4
1.2
u/ml
3.5
8.0
0.82
11
46
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
33
184
1.82
2.64
1.4
1.9
iu/l
2.7
4.4
—
9
63
(3014051) Protein [Presence] in Urine by Test strip
33
184
1.82
2.64
2.5
2.0
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
143
1106
1.34
2.61
1.6
1.4
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
85
602
1.45
2.60
5.3
3.6
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
11
38
2.92
2.58
1.5
1.3
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
24
121
2.01
2.57
2.3
1.8
g/l
0.8
1.0
0.15
19
95
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
5
7
7.17
2.55
1.0
1.0
—
—
—
0
0
(3036603) Volume of Urine
13
50
2.62
2.54
1.9
1.5
ml
1912.0
1999.3
—
5
13
(3030905) Polymorphonuclear cells [#/volume] in Blood
25
129
1.96
2.52
2.4
3.2
e9/l
4.1
4.5
0.43
25
129
(3003434) Protein [Mass/volume] in Pleural fluid
15
63
2.40
2.47
1.4
1.2
g/l
30.2
26.4
0.64
15
53
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
63
427
1.51
2.41
2.8
2.4
—
—
—
0
0
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
6
12
5.02
2.40
1.3
1.5
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
43
267
1.64
2.39
1.9
1.6
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
5
8
6.27
2.37
2.8
1.1
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
8
22
3.66
2.36
2.0
1.2
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
8
22
3.66
2.36
2.0
1.2
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
8
22
3.66
2.36
2.0
1.2
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
85
614
1.42
2.36
3.0
2.2
ml/min/173m2
68.4
67.1
0.12
39
248
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
44
277
1.62
2.32
2.2
1.7
ug/l
1.8
1.4
0.15
36
245
(3010144) Erythrocytes [#/volume] in Synovial fluid
17
78
2.20
2.32
1.1
1.3
e6/l
5468.3
241225.0
1.05
11
51
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
23
119
1.96
2.32
1.1
1.1
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
10
35
2.88
2.31
2.3
1.4
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
10
35
2.88
2.31
2.3
1.4
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
43
270
1.62
2.29
4.1
1.3
g/l
9.6
10.6
0.77
38
227
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
83
601
1.42
2.28
2.9
1.9
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
6
13
4.64
2.27
1.3
1.3
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
243
2052
1.24
2.25
4.1
3.2
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
9
29
3.12
2.23
1.6
1.4
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
9
29
3.12
2.23
1.6
1.4
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
75
537
1.43
2.20
2.7
1.8
—
—
—
0
0
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
8
24
3.35
2.18
1.4
2.6
%
202.6
125.6
—
8
24
(3037692) Legionella sp identified in Specimen by Organism specific culture
8
24
3.35
2.18
1.0
1.2
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
21
108
1.96
2.16
1.3
1.1
u/ml
1.3
1.5
0.49
11
31
(3048879) Bone marrow aspiration report
6
14
4.31
2.15
3.0
1.5
—
—
—
0
0
(3009343) pH of Capillary blood
68
481
1.44
2.13
5.4
3.6
ph
7.4
7.4
—
8
59
(21494755) Public health laboratory ask at order entry panel
46
687
0.65
2.13
1.2
1.4
—
—
—
0
0
(3036489) Thrombin time
40
252
1.61
2.12
1.8
1.9
s
20.5
21.4
0.72
35
222
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
56
382
1.49
2.11
9.0
9.9
—
—
—
0
0
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
57
392
1.48
2.07
2.8
2.2
%
1.2
1.2
0.03
57
392
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
13
56
2.34
2.05
1.1
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
13
56
2.34
2.05
1.1
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
13
56
2.34
2.05
1.1
1.1
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
15
69
2.19
2.05
2.3
2.8
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
6
15
4.02
2.04
1.3
1.0
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
23
125
1.86
2.04
3.6
2.7
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
15
70
2.16
1.99
1.1
1.2
u/ml
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
46
676
0.66
1.99
2.1
1.8
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
25
141
1.79
1.98
1.8
1.4
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
13
57
2.30
1.98
1.1
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
13
57
2.30
1.98
1.1
1.1
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
13
57
2.30
1.98
1.2
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
13
57
2.30
1.98
1.1
1.1
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
28
164
1.73
1.96
2.0
2.0
g/l
136.1
132.9
0.24
18
121
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
18
91
2.00
1.96
1.3
1.3
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
9
33
2.74
1.93
1.7
3.1
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
13
58
2.26
1.91
1.1
1.2
—
—
—
0
0
(3028308) Erythrocytes [#/volume] in Pleural fluid
12
52
2.32
1.88
1.6
1.3
e6/l
33820.0
130961.6
—
6
30
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
260
2253
1.21
1.85
1.7
1.7
mmol/l
1.4
1.4
0.35
215
1888
(3002619) Bacteria identified in Specimen by Culture
6
17
3.54
1.84
1.0
1.1
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
10
40
2.52
1.84
3.9
2.6
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
10
40
2.52
1.84
2.1
3.0
u/ml
616.2
1196.6
—
10
40
(3037522) Nuclear Ab [Titer] in Serum
132
1065
1.28
1.81
1.5
1.3
titre
570.4
592.6
0.04
27
242
(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection
7
23
3.06
1.80
1.0
2.0
—
2024630.0
—
0
5
(3023199) Leukocytes [#/volume] in Pleural fluid
13
60
2.18
1.78
1.5
1.3
e6/l
1046.8
2445.5
—
8
42
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
64
466
1.40
1.75
5.5
3.6
mmol/l
1.9
1.9
0.00
48
355
(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay
5
13
3.86
1.71
1.2
1.3
%
144.8
98.3
—
5
13
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
70
520
1.37
1.71
1.3
1.2
iu/ml
158.2
132.6
0.18
22
212
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
30
466
0.63
1.71
1.8
1.4
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
24
141
1.72
1.69
2.8
2.5
%
19.0
16.6
—
10
71
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
22
126
1.76
1.69
1.3
1.3
—
—
—
0
0
(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay
12
55
2.20
1.68
1.2
1.5
—
30.3
—
0
11
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
8
31
2.59
1.66
2.0
1.2
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
8
31
2.59
1.66
2.0
1.2
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
8
31
2.59
1.66
2.0
1.2
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
8
31
2.59
1.66
2.0
1.2
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
5
14
3.58
1.61
4.0
1.5
—
—
—
0
0
(4281824)
10
43
2.34
1.60
1.1
1.1
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
13
63
2.08
1.60
2.2
2.3
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
6
20
3.01
1.58
4.0
1.0
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
11
50
2.21
1.57
1.5
1.3
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
238
2076
1.19
1.57
4.5
3.9
estimate
0.0
0.0
0.69
84
653
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
39
265
1.49
1.55
4.6
1.6
u/ml
18.8
19.5
0.06
39
255
(3005322) IgE [Units/volume] in Serum or Plasma
67
503
1.36
1.55
1.2
1.3
u/ml
192.6
251.4
0.34
62
463
(3022313) Gas panel - Capillary blood
50
357
1.42
1.55
5.7
3.8
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
25
153
1.65
1.54
1.9
1.5
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
17
93
1.84
1.52
1.4
1.7
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
204
1760
1.20
1.52
1.8
1.7
pmol/l
93293143.1
27778205.1
0.46
164
1458
(3028433) Virus identified in Specimen by Culture
7
27
2.60
1.51
1.0
1.1
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
7
27
2.60
1.51
1.6
1.1
ug/l
10.5
9.5
—
7
27
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
19
108
1.77
1.51
1.2
1.1
u/ml
0.3
1.9
—
6
41
(3014765) Yersinia sp identified in Stool by Organism specific culture
33
218
1.53
1.50
1.2
1.1
—
—
—
0
0
(4268621)
14
72
1.96
1.49
2.6
2.1
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
9
37
2.45
1.48
4.2
1.4
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
10
45
2.23
1.46
2.7
2.3
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
54
396
1.38
1.46
1.0
1.0
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
9
38
2.38
1.46
1.6
1.3
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
79
615
1.31
1.45
4.1
3.7
ng/l
89.7
86.0
0.07
63
542
(3045142) Bone marrow Pathology biopsy report
12
59
2.05
1.44
1.4
1.2
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
87
688
1.29
1.43
2.7
3.0
ng/l
261.7
186.6
0.46
80
635
(42529406) Shigella sp [Presence] in Stool by Culture
33
221
1.51
1.42
1.2
1.2
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
798
7694
1.19
1.41
6.5
6.0
mmol/mol
40.1
40.2
0.06
726
7136
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
7
29
2.42
1.39
1.1
1.4
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
23
142
1.63
1.39
1.1
1.6
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
78
611
1.30
1.38
1.2
1.2
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
9
41
2.21
1.37
1.2
1.4
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
6
23
2.62
1.37
2.7
1.5
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
5
17
2.95
1.36
1.2
1.2
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
20
120
1.68
1.35
1.1
1.2
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
20
120
1.68
1.35
1.4
1.2
u/ml
533.5
238.7
0.74
14
71
(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma
12
61
1.98
1.33
1.1
1.0
mg/l
288.7
282.1
0.12
12
55
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
170
1462
1.20
1.32
2.7
2.6
ug/l
0.7
0.7
0.42
116
943
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
17
98
1.75
1.31
1.0
1.3
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
21
129
1.64
1.30
1.3
1.1
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
21
129
1.64
1.30
2.1
1.6
—
—
—
0
0
(4198724)
6
24
2.51
1.30
2.2
1.1
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
32
218
1.48
1.29
1.2
1.1
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
71
556
1.30
1.27
2.5
2.4
—
18.9
—
0
20
(3037121) Protein [Mass/volume] in Urine
35
244
1.45
1.27
4.3
2.9
g/l
0.4
0.3
0.59
17
88
(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma
8
36
2.23
1.24
1.0
1.1
u/l
33.9
17.9
—
8
25
(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma
8
36
2.23
1.24
1.0
1.1
u/l
70.3
65.3
—
8
26
(44806118)
13
70
1.87
1.24
1.2
1.5
—
—
—
0
0
(44790049)
13
70
1.87
1.24
1.2
1.5
—
—
—
0
0
(44790047)
13
70
1.87
1.24
1.2
1.5
—
—
—
0
0
(44790048)
13
70
1.87
1.24
1.2
1.5
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
17
100
1.71
1.24
1.4
1.3
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
330
3009
1.15
1.22
4.6
3.7
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
49
366
1.36
1.22
1.4
1.3
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
5
19
2.64
1.21
1.0
1.1
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
27
182
1.50
1.16
1.4
1.2
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
15
87
1.74
1.15
1.4
1.4
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
16
95
1.70
1.14
1.0
1.1
u/ml
0.5
1.5
—
6
37
(3034770) Mitochondria Ab [Titer] in Serum
29
201
1.46
1.11
1.1
1.2
—
1610.0
—
0
5
(40768441) Liver Pathology biopsy report
8
41
1.96
1.09
1.4
1.3
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
33
236
1.41
1.08
1.5
1.3
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
10
52
1.93
1.06
1.1
1.1
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
54
420
1.30
1.05
4.5
3.3
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
9
46
1.97
1.03
1.3
1.3
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
16
98
1.64
1.03
1.0
1.0
u/ml
12.1
6.1
—
7
50
(3010503) CD19 cells [#/volume] in Blood
5
22
2.28
1.03
5.0
1.9
e9/l
0.2
0.2
—
5
22
(3003129) Base excess in Capillary blood by calculation
5
22
2.28
1.03
2.2
1.5
mmol/l
1.5
1.4
—
5
22
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
24
163
1.48
1.02
1.8
2.0
pmol/l
169.6
212.8
1.34
24
152
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
10
53
1.90
1.01
1.1
1.2
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
230
2072
1.14
1.01
3.7
3.6
%
20.0
23.8
2.96
89
936
(3012565) Volume of 24 hour Urine
7
35
2.01
1.00
1.3
1.9
ml
2194.3
2259.8
—
7
30
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
27
189
1.44
1.00
1.5
1.4
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
19
124
1.54
0.97
1.2
1.1
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
17
108
1.58
0.97
1.2
1.3
—
—
—
0
0
(3020961) Endomysium IgA Ab [Titer] in Serum
45
346
1.31
0.96
1.0
1.1
—
149.0
—
0
9
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
0
31
0.00
0.96
0.0
1.1
—
1853.1
—
0
31
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
9
51
1.77
0.94
1.4
1.2
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
19
125
1.53
0.94
1.4
1.4
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
17
109
1.57
0.94
1.1
1.1
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
10
55
1.83
0.92
1.8
1.2
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
10
55
1.83
0.92
1.8
1.2
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
10
55
1.83
0.92
1.8
1.2
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
27
193
1.41
0.91
1.4
1.2
miu/ml
156.9
241.1
0.60
14
80
(4306422)
17
110
1.56
0.91
1.2
1.2
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
11
63
1.75
0.90
1.8
1.4
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
30
220
1.38
0.88
1.4
1.2
u/ml
5.8
11.1
—
5
33
(3051593) INR in Capillary blood by Coagulation assay
8
44
1.82
0.86
1.1
12.9
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
36
274
1.33
0.85
1.6
2.0
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
16
104
1.55
0.85
2.9
3.0
—
—
—
0
0
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
6
31
1.94
0.84
2.3
1.2
umol/l
38.0
30.4
—
6
31
(3017704) Immunofixation for Urine
8
46
1.75
0.82
2.6
1.1
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
12
73
1.65
0.82
1.8
1.3
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
6
33
1.82
0.79
1.5
1.4
—
—
—
0
0
(1002224) Polysomnography panel
43
341
1.27
0.77
1.1
1.1
—
—
—
0
0
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
46
368
1.26
0.77
5.2
3.1
%
47.8
49.5
0.18
46
362
(3024932) HLA-DR beta [Type]
5
24
2.09
0.74
1.0
1.1
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
7
38
1.85
0.73
1.0
1.0
—
—
—
0
0
(3024471) HLA-A [Type]
5
25
2.00
0.72
1.0
1.0
—
—
—
0
0
(4062490)
12
76
1.59
0.72
1.5
1.3
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
12
76
1.59
0.72
1.3
1.5
—
—
—
0
0
(3026470) Cobalt [Mass/volume] in Blood
9
58
1.56
0.70
1.9
2.0
ug/l
1.4
3.2
—
9
53
(3027008) Opiates [Presence] in Urine
27
204
1.33
0.69
2.0
1.7
—
—
—
0
0
(21494434) Karyotype in Bone marrow
10
61
1.65
0.68
1.1
1.2
—
—
—
0
0
(3018405) Lactate [Moles/volume] in Arterial blood
22
295
0.74
0.68
3.8
3.6
mmol/l
1.8
1.4
0.52
22
290
(3028300) Cannabinoids [Presence] in Urine
27
205
1.33
0.67
2.0
1.7
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
17
119
1.44
0.67
4.2
2.7
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
14
94
1.50
0.67
1.8
2.0
—
—
—
0
0
(3035880) pH of Pleural fluid
5
28
1.79
0.66
1.2
1.1
—
—
—
0
0
(3010726) Horse dander IgE Ab [Units/volume] in Serum
13
86
1.52
0.66
1.1
1.0
—
4.0
—
0
18
(3020891) Body temperature
25
324
0.77
0.62
4.0
4.2
—
—
—
0
0
(3038515) Glucose [Moles/volume] in Venous blood
23
173
1.34
0.62
6.1
2.7
mmol/l
8.1
7.3
0.54
23
168
(44813793)
8
49
1.64
0.62
1.0
1.0
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
14
96
1.46
0.61
1.0
1.2
nmol/l
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
40
326
1.24
0.60
2.4
2.0
u/l
40.8
40.2
0.07
35
282
(3008037) Lactate [Moles/volume] in Venous blood
24
183
1.32
0.60
5.9
2.6
mmol/l
1.5
1.5
0.14
24
178
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
30
237
1.27
0.59
1.6
1.4
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
34
273
1.25
0.58
2.6
1.8
—
—
—
0
0
(4094501)
31
246
1.27
0.58
1.0
1.1
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
7
114
0.61
0.58
1.0
1.0
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
26
202
1.29
0.57
2.1
1.7
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
6
36
1.67
0.56
1.2
1.3
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
5
89
0.56
0.56
2.0
1.5
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
59
505
1.18
0.56
1.6
1.5
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
5
90
0.55
0.56
1.0
1.1
—
—
—
0
0
(3000012) Reticulocyte production index
6
37
1.63
0.55
1.7
1.8
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
156
1430
1.11
0.55
1.3
1.3
iu/ml
37.4
34.2
0.11
49
475
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
8
126
0.63
0.54
1.0
1.1
—
129.2
—
0
26
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
10
66
1.52
0.52
1.0
1.0
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
9
63
1.43
0.52
4.7
1.1
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
9
63
1.43
0.52
1.0
1.1
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
6
40
1.50
0.51
1.0
1.1
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
7
45
1.56
0.49
1.4
1.4
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
24
190
1.27
0.48
2.0
1.7
—
—
—
0
0
(3038026) Centromere Ab [Units/volume] in Serum
11
76
1.45
0.48
1.3
1.1
—
88.8
—
0
5
(3019060) Gas panel - Arterial blood
58
505
1.16
0.47
4.1
4.7
—
—
—
0
0
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
7
48
1.46
0.47
28.4
15.5
nmol/l
1615.7
1492.2
—
7
48
(3024263) Appearance of Synovial fluid
7
49
1.43
0.46
2.9
1.6
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
7
49
1.43
0.46
1.6
2.5
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
17
129
1.32
0.46
2.4
2.6
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
5
82
0.61
0.46
1.0
1.2
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
25
201
1.25
0.45
2.2
1.5
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
192
1800
1.08
0.43
3.9
4.0
kg/l
1.0
1.0
0.17
23
259
(3017817) Protein [Mass] in Urine collected for unspecified duration
10
70
1.43
0.41
3.5
1.6
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
10
70
1.43
0.41
1.4
1.2
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
14
105
1.34
0.41
5.3
2.1
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
0
16
0.00
0.41
0.0
1.1
—
1.8
—
0
16
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
0
18
0.00
0.40
0.0
1.3
—
—
—
0
0
(3011648) Oxygen content in Venous blood
9
66
1.37
0.38
2.2
1.8
%
12.0
10.4
—
9
66
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
9
67
1.35
0.38
1.0
1.0
—
1.1
—
0
14
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
9
68
1.33
0.37
1.1
1.1
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
14
107
1.31
0.37
1.0
1.1
—
—
—
0
0
(3041354) Potassium [Moles/volume] in Venous blood
14
107
1.31
0.37
5.3
2.1
mmol/l
4.2
4.1
0.29
14
107
(3035285) Chloride [Moles/volume] in Venous blood
14
107
1.31
0.37
5.3
2.1
mmol/l
104.5
105.5
0.19
14
107
(3047007) Chlamydophila sp Ab [Presence] in Serum
14
107
1.31
0.37
1.1
1.3
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
26
216
1.21
0.37
2.7
1.7
—
—
—
0
0
(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal
5
78
0.64
0.35
1.2
1.2
nmol/l
1.2
1.4
—
5
69
(3019977) pH of Arterial blood
6
42
1.43
0.35
2.3
2.6
—
7.4
—
0
12
(3004451) EKG impression Narrative
6
42
1.43
0.35
1.5
1.3
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
22
181
1.22
0.34
4.4
3.8
mg/l
37.6
25.4
0.63
17
120
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
6
44
1.37
0.34
1.0
1.0
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
16
128
1.25
0.32
1.3
1.1
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
14
110
1.28
0.32
1.6
1.2
—
—
—
0
0
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
17
208
0.81
0.31
1.3
1.3
mg/l
576.5
480.1
0.37
17
196
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
842
8333
1.07
0.31
5.6
5.2
mmol/l
2.8
2.7
0.75
762
7672
(3003740) Influenza virus B Ag [Presence] in Specimen
14
111
1.27
0.30
1.2
1.1
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
14
112
1.25
0.28
1.2
1.1
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
19
158
1.21
0.28
2.2
1.7
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
9
121
0.74
0.27
1.3
1.4
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
23
196
1.18
0.27
1.3
1.1
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
12
95
1.27
0.26
1.0
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
12
95
1.27
0.26
1.0
1.4
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
26
225
1.16
0.26
1.7
1.6
iu/ml
0.3
0.1
—
9
44
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
12
96
1.25
0.24
1.0
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
12
96
1.25
0.24
1.0
1.4
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
144
1370
1.06
0.24
1.2
1.3
u/ml
1.8
12.7
7.64
34
531
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
819
8114
1.06
0.24
5.0
4.6
mmol/l
1.5
1.5
0.36
739
7467
(3019897) Erythrocyte distribution width [Ratio] by Automated count
6
83
0.72
0.24
3.7
3.3
%
13.2
13.2
—
6
83
(40761535) Cells panel - Urine sediment
73
678
1.08
0.24
3.7
3.2
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
20
233
0.86
0.24
1.9
2.3
ug/min
24.7
118.5
1.68
11
143
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
5
38
1.32
0.23
1.2
1.3
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
0
10
0.00
0.21
0.0
3.1
—
0.5
—
0
10
(3013247) Albumin in CSF/Albumin in Serum or Plasma
0
12
0.00
0.21
0.0
1.0
—
6.5
—
0
12
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
5
43
1.16
0.21
1.2
1.0
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
112
1064
1.06
0.21
7.6
6.5
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
1.4
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid
0
14
0.00
0.20
0.0
1.1
—
41.4
—
0
5
(1761482) Bacteria [#/volume] in Urine by Culture
24
212
1.14
0.19
7.9
4.1
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
12
99
1.21
0.19
1.8
1.7
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
6
51
1.18
0.19
1.0
1.3
nmol/l
131.7
153.7
—
6
51
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
22
249
0.88
0.19
1.8
1.8
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
10
81
1.24
0.18
1.4
1.2
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
7
59
1.19
0.18
1.3
1.2
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
7
60
1.17
0.18
2.4
1.5
g/l
0.9
1.0
—
7
60
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
7
62
1.13
0.17
1.1
1.0
ng/l
169.0
342.6
—
7
38
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
80
758
1.06
0.17
2.3
2.5
ug/l
8.7
7.8
0.13
65
671
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
7
63
1.11
0.17
1.1
1.0
ng/l
849.9
673.2
—
7
37
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
7
63
1.11
0.17
1.1
1.0
ng/l
14.7
49.4
—
7
37
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
111
1063
1.05
0.16
4.8
4.7
%
32.1
32.4
0.10
68
704
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
8
68
1.18
0.16
1.1
1.6
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
9
78
1.16
0.15
1.1
1.0
—
1.8
—
0
27
(3008898) HLA-B27 [Presence]
24
265
0.90
0.15
1.0
1.1
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
9
83
1.09
0.14
1.9
1.3
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
823
8181
1.04
0.14
5.1
4.7
mmol/l
4.7
4.7
0.26
749
7567
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
21
229
0.92
0.11
1.3
1.5
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
88
911
0.96
0.10
1.7
1.6
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
5
47
1.06
0.09
1.2
1.1
—
—
—
0
0
(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma
6
55
1.09
0.09
1.3
1.3
u/l
4.8
6.2
—
6
45
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
10
88
1.14
0.08
1.1
1.1
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
8
78
1.03
0.07
1.5
1.3
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
268
2713
0.98
0.07
4.7
4.0
mg/mmol
17.1
7.4
0.67
173
1712
(3047352) Trisomy 18 risk [Likelihood] in Fetus
7
81
0.86
0.07
1.0
1.4
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
7
80
0.87
0.07
1.0
1.4
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
7
82
0.85
0.07
1.0
1.5
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
782
7850
0.98
0.07
4.5
4.1
mmol/l
1.4
1.3
1.23
701
7168
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
9
86
1.05
0.07
1.2
1.1
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
9
100
0.90
0.06
1.2
1.1
—
—
—
0
0
(4146454)
9
105
0.86
0.06
2.8
2.7
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
30
314
0.95
0.05
1.5
1.7
mg/l
3.4
5.0
0.35
22
228
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
17
182
0.93
0.05
1.5
1.3
e6/l
2736.3
764.7
0.31
11
153
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
17
182
0.93
0.05
1.4
1.2
e6/l
1.2
52.0
—
9
150
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
11
119
0.92
0.04
1.1
1.5
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
15
159
0.94
0.03
1.6
1.6
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
17
161
1.06
0.03
1.4
1.2
—
—
—
0
0
(4034850)
29
299
0.97
0.02
9.8
9.3
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
258
2566
1.01
0.02
3.6
3.2
mg/l
313.2
168.8
0.26
165
1603
(3001019) Free T4 and TSH panel - Serum or Plasma
36
369
0.97
0.02
1.6
1.7
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
18
173
1.04
0.01
1.3
1.8
nmol/l
0.8
0.8
0.03
13
140
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
56
553
1.01
0.01
1.3
1.4
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
11
104
1.06
0.01
1.1
1.6
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
18
186
0.97
0.00
1.4
1.5
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
17
166
1.02
0.00
1.8
1.2
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
270
2697
1.00
0.00
3.6
3.1
mmol/l
7.3
7.5
0.38
226
2293
(4024509)
7
74
0.95
0.00
1.7
1.6
—
—
—
0
0
(3041672) Baker's yeast Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.8
—
9.7
—
0
6
(3042552) Rheumatoid factor [Units/volume] in Pleural fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
8
79
1.01
0.00
1.5
2.2
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
5
50
1.00
0.00
2.6
2.0
—
—
—
0
0
(3022411) Androstenedione [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
5.6
—
0
6
(3019768) Coxiella burnetii Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3012984) Norclozapine [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
9.0
—
—
—
0
0
(3020393) Adenovirus Ag [Presence] in Stool
0
5
0.00
0.00
0.0
2.8
—
—
—
0
0
(3004269) Kappa light chains [Mass/time] in 24 hour Urine
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
9
91
0.99
0.00
1.2
1.1
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
7
79
0.89
0.00
1.1
1.1
—
—
—
0
0
(3032700) Glomerular basement membrane Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013762) Body weight Measured
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose
0
5
0.00
0.00
0.0
1.2
—
7.5
—
0
5
(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3002621) Streptococcal DNAse B [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3034092) Cytoplasmic Ig cells/100 cells in Blood
0
9
0.00
0.00
0.0
14.9
—
—
—
0
0
(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
5
59
0.85
0.00
1.2
1.2
—
—
—
0
0
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
7
75
0.93
0.00
3.7
2.1
—
1.7
—
0
34
(40765089) Chromosome analysis panel - Blood by G-banded
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3041806) Other cells [#/volume] in Blood by Manual count
0
9
0.00
0.00
0.0
1.7
—
—
—
0
0
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: CD2_BENIGN_TONGUE_EXALLC – Benign neoplasm: Tongue

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).